BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 12631440)

  • 1. Oxidative stress in ataxia telangiectasia.
    Watters DJ
    Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide.
    Lee JH; Kim KH; Morio T; Kim H
    Ann N Y Acad Sci; 2006 Dec; 1091():76-82. PubMed ID: 17341604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage.
    Barzilai A; Rotman G; Shiloh Y
    DNA Repair (Amst); 2002 Jan; 1(1):3-25. PubMed ID: 12509294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
    Stewart GS; Last JI; Stankovic T; Haites N; Kidd AM; Byrd PJ; Taylor AM
    J Biol Chem; 2001 Aug; 276(32):30133-41. PubMed ID: 11382771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
    Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
    FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?
    Rotman G; Shiloh Y
    Bioessays; 1997 Oct; 19(10):911-7. PubMed ID: 9363685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated oxidative stress in patients with ataxia telangiectasia.
    Reichenbach J; Schubert R; Schindler D; Müller K; Böhles H; Zielen S
    Antioxid Redox Signal; 2002 Jun; 4(3):465-9. PubMed ID: 12215213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM and the molecular pathogenesis of ataxia telangiectasia.
    McKinnon PJ
    Annu Rev Pathol; 2012; 7():303-21. PubMed ID: 22035194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
    Lavin MF; Khanna KK
    Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
    Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM and ataxia telangiectasia.
    McKinnon PJ
    EMBO Rep; 2004 Aug; 5(8):772-6. PubMed ID: 15289825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic defect in ataxia-telangiectasia.
    Lavin MF; Shiloh Y
    Annu Rev Immunol; 1997; 15():177-202. PubMed ID: 9143686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.
    Ziv S; Brenner O; Amariglio N; Smorodinsky NI; Galron R; Carrion DV; Zhang W; Sharma GG; Pandita RK; Agarwal M; Elkon R; Katzin N; Bar-Am I; Pandita TK; Kucherlapati R; Rechavi G; Shiloh Y; Barzilai A
    Hum Mol Genet; 2005 Oct; 14(19):2929-43. PubMed ID: 16150740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM signaling and genomic stability in response to DNA damage.
    Lavin MF; Birrell G; Chen P; Kozlov S; Scott S; Gueven N
    Mutat Res; 2005 Jan; 569(1-2):123-32. PubMed ID: 15603757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination capabilities in response to neocarzinostatin and H(2)O(2) stress in cell lines from patients with ataxia-telangiectasia.
    Taylor A; Shang F; Nowell T; Galanty Y; Shiloh Y
    Oncogene; 2002 Jun; 21(28):4363-73. PubMed ID: 12080467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ataxia telangiectasia syndrome: moonlighting ATM.
    Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.
    Balmus G; Zhu M; Mukherjee S; Lyndaker AM; Hume KR; Lee J; Riccio ML; Reeves AP; Sutter NB; Noden DM; Peters RM; Weiss RS
    Hum Mol Genet; 2012 Aug; 21(15):3408-20. PubMed ID: 22575700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.
    Ambrose M; Gatti RA
    Blood; 2013 May; 121(20):4036-45. PubMed ID: 23440242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.
    Biton S; Barzilai A; Shiloh Y
    DNA Repair (Amst); 2008 Jul; 7(7):1028-38. PubMed ID: 18456574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.